Previous studies have investigated the possible prognostic impact of differentiation markers in AML, including CD34 expression and Sudan black staining; these early studies suggested that such markers had no/uncertain prognostic impact [147,148], whereas certain recent studies suggest that CD34 expression is important in certain AML subsets [149,150]. Here, CD34 is linked to acute myeloid leukemia.